Lifecycle activities for products including pre-authorization to submission, submission to launch, commercial (including post-approval commitments and post-approval changes), additional indications (line extensions), divestments, Pharmacopoeia Affairs (USA, Europe, China). All Good X Practice (GXP) domains; Current Good Manufacturing Practice (cGMP), Good Distribution Practice (GDP), Good Pharmacovigilance Practice (GVP), Good Clinical Practice (GCP), Good Clinical Laboratory Practice (GCLP), and Data Integrity.